Telcagepant - paediatric investigation plan

Telcagepant

Key facts

• Active Substance:
  Telcagepant
• Therapeutic area:
  Pain
• Decision number:
  P/44/2011
• PIP number:
  Telcagepant
• Pharmaceutical form(s):
  • Film-coated tablet
  • Age-appropriate dosage form, other
• Condition(s) / indication(s):
  Migraine with or without aura
• Route(s) of administration:
  Oral use
• Contact for public enquiries:

  Merck Sharp & Dohme (Europe), Inc

  Belgium; Tel. [phone]; E-mail: [e-mail]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  03/03/2011

Decision

P/44/2011: EMA decision of 3 March 2011 on the acceptance of a modification of an agreed paediatric investigation plan for telcagepant (EMEA-000274-PIP01-08-M01) in accordance with Regulation (EC) No 1901/2006 of the Eur...

AdoptedReference Number: EMA/115432/2011